| 0.628 Data as of Jun 17 |  +0.05 / +8.65%Today’s Change | 0.40 Today|||52-Week Range 1.20 | +4.68% Year-to-Date |
| Previous close | 0.58 |
| Today’s open | 0.63 |
| Day’s range | 0.58 - 0.63 |
| Volume | 88,465 |
| Average volume (3 months) | 107,977 |
| Market cap | $24.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +23.44% |
| Earnings growth (this year) | +56.12% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -95.00% |
| P/E ratio | NM |
| Price/Sales | 236.66 |
| Price/Book | 11.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| MSLIMerus Labs Internati... | -0.05 | -6.28% |
| ELTPElite Pharmaceutical... | 0.00 | 0.00% |
| PRPHProPhase Labs Inc | -0.04 | -2.55% |
| CRMECardiome Pharma Corp | +0.01 | +0.50% |
| Next reporting date | September 10, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $73.7K |
| Annual profit (last year) | -$17.3M |
| Net profit margin | -23,398.58% |
Sector Health Technology |
Industry Biotechnology |
Chairman John K. A. Prendergast, PhD |
President, Chief Executive Officer & Director Carl Spana, PhD |
Corporate headquarters Cranbury, New Jersey |
.
